CRB-701 / Corbus Pharma, CSPC Pharma  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
CRB-701 / CSPC Pharma, Corbus Pharma
SYS6002-001, CTR20222932: An open-label, single-arm, multicenter phase I clinical trial evaluating the safety, tolerability, pharmacokinetic profile, and preliminary efficacy of SYS6002 in patients with advanced solid tumors

Recruiting
1
380
China
CRB-701 - CSPC Pharma, Corbus Pharma
CSPC Pharmaceutical Group Jushi Biopharmaceutical Co., Ltd
Advanced solid tumors
 
 
ChiCTR2200066256: Phase I, Dose Escalation, PK Expansion and Cohort Expansion study of SYS6002 in Patients with Advanced Solid Tumors

Not yet recruiting
1
366
 
SYS6002
Fudan University Shanghai Cancer Center; CSPC Megalith Biopharmaceutical Co., Ltd.., CSPC Megalith Biopharmaceutical Co., Ltd..
Advanced Solid Tumors
 
 

Download Options